Lavo AI

0 reviews

Lavo Life Sciences offers AI-powered solutions to accelerate drug development by providing accurate crystal structure predictions. Their flagship product, the Crystal Console, is a web-based platform that enables pharmaceutical teams to predict stable crystal structures, explore polymorph landscapes, and optimize compounds through an intuitive interface. By integrating advanced AI algorithms and quantum mechanical calculations, Lavo's tools help de-risk pipelines, optimize solid-state formulations, and prevent late-stage surprises in the drug development process. Key Features and Functionality: - High-Throughput Virtual Screening: Rapidly discover potential polymorphs to mitigate development risks. - Interactive 3D Visualization: Analyze crystal structures with an intuitive interface for better understanding of molecular packing and stability. - Quantum Mechanical Calculations: Perform comprehensive structure analysis to assess stability and manufacturability. - PXRD Analysis: Upload, analyze, and compare powder X-ray diffraction data with predicted structures to identify likely polymorphs. Primary Value and Problem Solved: Lavo Life Sciences addresses the challenges of traditional polymorph screening, which can be time-consuming, costly, and limited in scope. By leveraging AI and computational chemistry, their solutions enable faster, more efficient, and accurate crystal structure predictions. This approach reduces the time and resources needed for crystal form identification, minimizes the risk of unexpected polymorphs impacting development timelines, and enhances decision-making in drug development. Ultimately, Lavo's technology streamlines the pharmaceutical research and development process, leading to more stable and manufacturable drug formulations.